Clinical Trial Details
| Trial ID: | L4889 |
| Source ID: | NCT01081938 |
| Associated Drug: | Insulin Glargine |
| Title: | Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition |
| Acronym: | |
| Status: | TERMINATED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: INSULIN GLARGINE|DRUG: INSULIN GLULISINE |
| Outcome Measures: | Primary: Glycaemic parameters assessment, During the period of 7 Days of treatment | Secondary: Incidence of moderate and severe hyperglycemia, During the period of 7 Days of treatment|Incidence of symptomatic, nocturnal and severe hypoglycemias, During the period of 7 Days of treatment |
| Sponsor/Collaborators: | Sponsor: Sanofi |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 15 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2010-02 |
| Completion Date: | 2011-02 |
| Results First Posted: | |
| Last Update Posted: | 2012-03-27 |
| Locations: | Sanofi-Aventis Investigational Site Number 076-007, Belo Horizonte, 30150-120, Brazil|Sanofi-Aventis Investigational Site Number 076-011, Curitiba, 80420-011, Brazil|Sanofi-Aventis Investigational Site Number 076-005, Joinville, Brazil|Sanofi-Aventis Investigational Site Number 076-001, Porto Alegre, 90035-001, Brazil|Sanofi-Aventis Investigational Site Number 076-004, Porto Alegre, 90035-003, Brazil|Sanofi-Aventis Investigational Site Number 076-006, São José do Rio Preto, 15090-000, Brazil|Sanofi-Aventis Investigational Site Number 076-010, São Paulo, 01232-010, Brazil|Sanofi-Aventis Investigational Site Number 076-008, São Paulo, 01308-050, Brazil|Sanofi-Aventis Investigational Site Number 076-003, São Paulo, 01323-020, Brazil|Sanofi-Aventis Investigational Site Number 076-009, São Paulo, 01323-900, Brazil |
| URL: | https://clinicaltrials.gov/show/NCT01081938 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|